NEW YORK, June 30, 2023 (GLOBE NEWSWIRE) — Athyrium Capital Management, LP announced that funds managed by it have sold an aggregate of 1,300,000 common shares of HLS Therapeutics (the “Corporation”) over the facilities of the Toronto Stock Exchange at an average sale price of C$5.775 per common share, representing approximately $7.5 million in the […]
Athyrium Capital Announces Sale of Shares of HLS Therapeutics
byAnand Gupta
-
0